Xeris Biopharma Holdings (XERS) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to -$12.2 million.
- Xeris Biopharma Holdings' Other Gross PP&E Adjustments rose 557.88% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year increase of 557.88%. This contributed to the annual value of -$19.5 million for FY2024, which is 298.17% down from last year.
- Latest data reveals that Xeris Biopharma Holdings reported Other Gross PP&E Adjustments of -$12.2 million as of Q3 2025, which was up 557.88% from -$15.0 million recorded in Q2 2025.
- Over the past 5 years, Xeris Biopharma Holdings' Other Gross PP&E Adjustments peaked at $11.0 million during Q2 2022, and registered a low of -$19.5 million during Q4 2024.
- For the 5-year period, Xeris Biopharma Holdings' Other Gross PP&E Adjustments averaged around -$7.7 million, with its median value being -$13.6 million (2023).
- Data for Xeris Biopharma Holdings' Other Gross PP&E Adjustments shows a peak YoY increase of 938.71% (in 2024) and a maximum YoY decrease of 542605.04% (in 2024) over the last 5 years.
- Over the past 5 years, Xeris Biopharma Holdings' Other Gross PP&E Adjustments (Quarter) stood at $7.6 million in 2021, then crashed by 82.28% to $1.3 million in 2022, then plummeted by 1509.9% to -$18.9 million in 2023, then dropped by 2.98% to -$19.5 million in 2024, then soared by 37.55% to -$12.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$12.2 million in Q3 2025, compared to -$15.0 million in Q2 2025 and -$17.8 million in Q1 2025.